Yüklüyor......
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
OBJECTIVE: To investigate the statistical power of plasma, imaging, and cognition biomarkers as Alzheimer’s disease (AD) clinical trial outcome measures. METHODS: Plasma neurofilament light, structural magnetic resonance imaging, and cognition were measured longitudinally in the Alzheimer’s Disease...
Kaydedildi:
| Yayımlandı: | Ann Clin Transl Neurol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480920/ https://ncbi.nlm.nih.gov/pubmed/32779869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51158 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|